Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today
One of the company's pipeline drugs is showing significant promise. Clinical-stage biotech Nektar Therapeutics (NKTR 15.06%) had some encouraging news to report from the lab…
One of the company's pipeline drugs is showing significant promise. Clinical-stage biotech Nektar Therapeutics (NKTR 15.06%) had some encouraging news to report from the lab…